Scilex Holding Company announced a national leading pharmacy chain to stock ELYXYB®. Previously, Scilex Holding Company announced pharmacy initiative to stock ELYXYB® for the other leading pharmacy chain in the U.S.Scilex is also in the process of negotiating similar potential stocking arrangements with additional pharmacy chains in the U.S. ELYXYB® is the first and only ready to use oral solution designed to deliver fast and long-lasting migraine relief with the proven safety of COX-2 selectivity that is FDA-approved for the acute treatment of migraine, with or without aura, in adults. National leading pharmacy chain to stock ELYXYB® in most of their stores throughout the U.S. Previously, Scilex Holding Company announced pharmacy initiative to stock ELYXYB® for the other leading pharmacy chain in the U.S. Scilex is also in the process of negotiating similar potential stocking arrangements with additional pharmacy chains remaining in the U.S.